BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly specialized formulation features glycosylphosphatidylinositol-anchored New York esophageal squamous cell carcinoma 1 fusion protein integrated cell membrane lipids (gpi-ny-eso-1 fusion protein cell membrane lipids). The macromolecular architecture consists of a stable phospholipid bilayer matrix engineered to express and accommodate the recombinant fusion protein New York esophageal squamous cell carcinoma 1 (NY-ESO-1) covalently linked via a glycosylphosphatidylinositol (GPI) lipid anchor. The incorporation of the amphiphilic glycosylphosphatidylinositol anchors directs the orientation of the protein outward from the bilayer interface, presenting a dense macromolecular antigen array that modifies the overall surface typography and charge profile.
Source
Custom synthesis
Functional Group
gpi-ny-eso-1 fusion protein; Cell membrane lipids
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.